Sanofi, Genzyme reach agreement at $74 plus CVR

BOSTON Tue Feb 15, 2011 12:21pm EST

BOSTON Feb 15 (Reuters) - Sanofi-Aventis SA (SASY.PA) and Genzyme Corp GENZ.O have reached an agreement in principle under which Sanofi will acquire Genzyme for $74 a share in cash plus a right to future payments based on the performance of Genzyme's experimental multiple sclerosis drug, according to a source with knowledge of the discussions.

The deal is expected to be announced by Wednesday morning, the source said. (Reporting by Toni Clarke, editing by Maureen Bavdek)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.